Baseline Antimullerian Hormone Level Does Not Serve as a Predictor of Uterine Fibroid Treatment Outcomes. The Journal of Reproductive Medicine, [S. l.], v. 68, n. 1, p. 576–590, 2025. Disponível em: https://www.thereproductivemedicine.com/Home/article/view/176.. Acesso em: 31 jul. 2025.